AMED Medical Center

Warsaw 01-518

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Rheumatoid Arthritis

Studies at this site

• Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants — Completed
• A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early
• Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) — Completed
• Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) — Completed